The global Alirocumab market size is expected to reach $3.48 billion in 2030 at a CAGR of 10.6%, driven by increasing prevalence of cardiovascular diseases.
Read MoreThe Advanced Lab Reagents market size is expected to reach $2.92 billion in 2030 at a CAGR of 11.8%, driven by increasing prevalence of chronic diseases.
Read MoreThe Adaptive Brain Pacemaker Devices market size is expected to reach $0.93 billion in 2030 at a CAGR of 19.8%, driven by rising prevalence of neurological disorders.
Read MoreThe Acetaminophen market size is expected to reach $11.79 billion in 2030 at a CAGR of 5.1%, driven by rising fever cases and growing OTC medication demand.
Read MoreThe wound skin substitutes market is projected to reach $1.91B by 2030, driven by chronic wound prevalence, diabetes growth, regenerative medicine, advanced wound care, and outpatient clinics.
Read MoreThe wearable neurotech market is projected to reach $5.34B by 2030, driven by remote neuro monitoring, cognitive enhancement tools, neurodigital therapeutics, and consumer brain-computer interfaces.
Read MoreThe wastewater biothreat genomics market is projected to reach $3.01B by 2030, driven by biosecurity investments, early outbreak detection, AI genomic analytics, and sewage-based pathogen surveillance.
Read MoreThe virtual ward market is projected to reach $5B by 2030, driven by home care adoption, remote patient monitoring, connected medical devices, and hospital-at-home models.
Read MoreThe virtual clinics market is projected to reach $21.93B by 2030, driven by hybrid care models, digital-first healthcare policies, remote diagnostics, and video consultation platforms.
Read MoreThe virtual care management market is projected to reach $19.82B by 2030, driven by value-based care, home monitoring programs, digital transformation, and remote patient management tools.
Read More